Intrinsic Edge Capital Management LLC Amicus Therapeutics, Inc. Transaction History
Intrinsic Edge Capital Management LLC
- $678 Million
- Q4 2024
A detailed history of Intrinsic Edge Capital Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 673,900 shares of FOLD stock, worth $6.19 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
673,900Holding current value
$6.19 Million% of portfolio
0.94%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$269 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$262 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$224 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$223 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$213 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.58B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...